BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schueller F, Roy S, Vucur M, Trautwein C, Luedde T, Roderburg C. The Role of miRNAs in the Pathophysiology of Liver Diseases and Toxicity. Int J Mol Sci. 2018;19:pii: E261. [PMID: 29337905 DOI: 10.3390/ijms19010261] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Golonka RM, Cooper JK, Issa R, Devarasetty PP, Gokula V, Busken J, Zubcevic J, Hill J, Vijay-Kumar M, Menon B, Joe B. Impact of Nutritional Epigenetics in Essential Hypertension: Targeting microRNAs in the Gut-Liver Axis. Curr Hypertens Rep 2021;23:28. [PMID: 33961141 DOI: 10.1007/s11906-021-01142-9] [Reference Citation Analysis]
2 Arechederra M, Recalde M, Gárate-Rascón M, Fernández-Barrena MG, Ávila MA, Berasain C. Epigenetic Biomarkers for the Diagnosis and Treatment of Liver Disease. Cancers (Basel) 2021;13:1265. [PMID: 33809263 DOI: 10.3390/cancers13061265] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 El-Sebaey AM, Abramov PN. Hepatocyte-derived canine familiaris-microRNAs as serum biomarkers of hepatic steatosis or fibrosis as implicated in the pathogenesis of canine cholecystolithiasis. Vet Clin Pathol 2021. [PMID: 34031917 DOI: 10.1111/vcp.12942] [Reference Citation Analysis]
4 Du B, Tan XH, Cheng L, Wang F, Zhang HF. MiR-451a ameliorates alcoholic hepatitis via repressing HDAC8-mediated proinflammatory response. Kaohsiung J Med Sci 2020;36:904-10. [PMID: 32643864 DOI: 10.1002/kjm2.12272] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Tomlinson JE, Wolfisberg R, Fahnøe U, Patel RS, Trivedi S, Kumar A, Sharma H, Nielsen L, McDonough SP, Bukh J, Tennant BC, Kapoor A, Rosenberg BR, Rice CM, Divers TJ, Van de Walle GR, Scheel TKH. Pathogenesis, MicroRNA-122 Gene-Regulation, and Protective Immune Responses After Acute Equine Hepacivirus Infection. Hepatology 2021. [PMID: 33713356 DOI: 10.1002/hep.31802] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Sangiao-Alvarellos S, Theofilatos K, Barwari T, Gutmann C, Takov K, Singh B, Juiz-Valiña P, Varela-Rodríguez BM, Outeiriño-Blanco E, Duregotti E, Zampetaki A, Lunger L, Ebenbichler C, Tilg H, García-Brao MJ, Willeit P, Mena E, Kiechl S, Cordido F, Mayr M. Metabolic recovery after weight loss surgery is reflected in serum microRNAs. BMJ Open Diabetes Res Care 2020;8:e001441. [PMID: 33115818 DOI: 10.1136/bmjdrc-2020-001441] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Reda El Sayed S, Cristante J, Guyon L, Denis J, Chabre O, Cherradi N. MicroRNA Therapeutics in Cancer: Current Advances and Challenges. Cancers (Basel) 2021;13:2680. [PMID: 34072348 DOI: 10.3390/cancers13112680] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
8 Bissoondial TL, Pellicano AJ, Goldberg ID, Narayan P. Identification of disease-associated microRNA in a diet-induced model of nonalcoholic steatohepatitis. Mol Omics 2021. [PMID: 34757352 DOI: 10.1039/d1mo00274k] [Reference Citation Analysis]
9 Li D, Knox B, Gong B, Chen S, Guo L, Liu Z, Tong W, Ning B. Identification of Translational microRNA Biomarker Candidates for Ketoconazole-Induced Liver Injury Using Next-Generation Sequencing. Toxicol Sci 2021;179:31-43. [PMID: 33078836 DOI: 10.1093/toxsci/kfaa162] [Reference Citation Analysis]
10 Roy S, Trautwein C, Luedde T, Roderburg C. A General Overview on Non-coding RNA-Based Diagnostic and Therapeutic Approaches for Liver Diseases. Front Pharmacol 2018;9:805. [PMID: 30158867 DOI: 10.3389/fphar.2018.00805] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
11 Balasubramaniyan N, Devereaux MW, Orlicky DJ, Sokol RJ, Suchy FJ. Up-regulation of miR-let7a-5p Leads to Decreased Expression of ABCC2 in Obstructive Cholestasis. Hepatol Commun 2019;3:1674-86. [PMID: 31832574 DOI: 10.1002/hep4.1433] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
12 Ye D, Zhang T, Lou G, Liu Y. Role of miR-223 in the pathophysiology of liver diseases. Exp Mol Med. 2018;50:128. [PMID: 30258086 DOI: 10.1038/s12276-018-0153-7] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 8.3] [Reference Citation Analysis]
13 Abu-Halima M, Meese E, Saleh MA, Keller A, Abdul-Khaliq H, Raedle-Hurst T. MicroRNA-29b/c-3p Indicate Advanced Liver Fibrosis/Cirrhosis in Univentricular Heart Patients With and Without Fontan Palliation. Front Cardiovasc Med 2020;7:619083. [PMID: 33490119 DOI: 10.3389/fcvm.2020.619083] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Konovalova J, Gerasymchuk D, Arroyo SN, Kluske S, Mastroianni F, Pereyra AV, Domanskyi A. Human-Specific Regulation of Neurotrophic Factors MANF and CDNF by microRNAs. Int J Mol Sci 2021;22:9691. [PMID: 34575854 DOI: 10.3390/ijms22189691] [Reference Citation Analysis]
15 El-Sebaey AM, Abramov PN, Abdelhamid FM. Clinical Characteristics, Serum Biochemical Changes, and Expression Profile of Serum Cfa-miRNAs in Dogs Confirmed to Have Congenital Portosystemic Shunts Accompanied by Liver Pathologies. Vet Sci 2020;7:E35. [PMID: 32218339 DOI: 10.3390/vetsci7020035] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
16 Roderburg C, Koch A, Benz F, Vucur M, Spehlmann M, Loosen SH, Luedde M, Rehse S, Lurje G, Trautwein C, Tacke F, Luedde T. Serum Levels of miR-143 Predict Survival in Critically Ill Patients. Dis Markers 2019;2019:4850472. [PMID: 31772686 DOI: 10.1155/2019/4850472] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Zhang X, Mens MMJ, Abozaid YJ, Bos D, Darwish Murad S, de Knegt RJ, Ikram MA, Pan Q, Ghanbari M. Circulatory microRNAs as potential biomarkers for fatty liver disease: the Rotterdam study. Aliment Pharmacol Ther 2021;53:432-42. [PMID: 33244812 DOI: 10.1111/apt.16177] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
18 Bruneau A, Hundertmark J, Guillot A, Tacke F. Molecular and Cellular Mediators of the Gut-Liver Axis in the Progression of Liver Diseases. Front Med (Lausanne) 2021;8:725390. [PMID: 34650994 DOI: 10.3389/fmed.2021.725390] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Blaya D, Pose E, Coll M, Lozano JJ, Graupera I, Schierwagen R, Jansen C, Castro P, Fernandez S, Sidorova J, Vasa-Nicotera M, Solà E, Caballería J, Trebicka J, Ginès P, Sancho-Bru P. Profiling circulating microRNAs in patients with cirrhosis and acute-on-chronic liver failure. JHEP Rep 2021;3:100233. [PMID: 33665588 DOI: 10.1016/j.jhepr.2021.100233] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Teschke R. Idiosyncratic DILI: Analysis of 46,266 Cases Assessed for Causality by RUCAM and Published From 2014 to Early 2019. Front Pharmacol 2019;10:730. [PMID: 31396080 DOI: 10.3389/fphar.2019.00730] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 8.7] [Reference Citation Analysis]
21 Huang PS, Liao CJ, Huang YH, Yeh CT, Chen CY, Tang HC, Chang CC, Lin KH. Functional and Clinical Significance of Dysregulated microRNAs in Liver Cancer. Cancers (Basel) 2021;13:5361. [PMID: 34771525 DOI: 10.3390/cancers13215361] [Reference Citation Analysis]
22 Teschke R. Hepatotoxicity: Molecular Mechanisms and Pathophysiology. Int J Mol Sci 2019;20:E211. [PMID: 30626076 DOI: 10.3390/ijms20010211] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Loosen SH, Castoldi M, Jördens MS, Roy S, Vucur M, Kandler J, Hammerich L, Mohr R, Tacke F, Ulmer TF, Neumann UP, Luedde T, Roderburg C. Serum levels of circulating microRNA-107 are elevated in patients with early-stage HCC. PLoS One 2021;16:e0247917. [PMID: 33711036 DOI: 10.1371/journal.pone.0247917] [Reference Citation Analysis]
24 Drescher HK, Weiskirchen S, Weiskirchen R. Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH). Cells 2019;8:E845. [PMID: 31394730 DOI: 10.3390/cells8080845] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 15.0] [Reference Citation Analysis]
25 Geisler L, Mohr R, Lambrecht J, Knorr J, Jann H, Loosen SH, Özdirik B, Luedde T, Hammerich L, Tacke F, Wree A, Hellberg T, Roderburg C. The Role of miRNA in the Pathophysiology of Neuroendocrine Tumors. Int J Mol Sci 2021;22:8569. [PMID: 34445276 DOI: 10.3390/ijms22168569] [Reference Citation Analysis]
26 Hukowska-Szematowicz B, Maciejak-Jastrzębska A, Blatkiewicz M, Maciak K, Góra M, Janiszewska J, Burzyńska B. Changes in MicroRNA Expression during Rabbit Hemorrhagic Disease Virus (RHDV) Infection. Viruses 2020;12:E965. [PMID: 32878241 DOI: 10.3390/v12090965] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Xie ZY, Liu MS, Zhang C, Cai PC, Xiao ZH, Wang FF. Aspirin enhances the sensitivity of hepatocellular carcinoma side population cells to doxorubicin via miR-491/ABCG2. Biosci Rep 2018;38:BSR20180854. [PMID: 30120100 DOI: 10.1042/BSR20180854] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
28 Markovic J, Sharma AD, Balakrishnan A. MicroRNA-221: A Fine Tuner and Potential Biomarker of Chronic Liver Injury. Cells 2020;9:E1767. [PMID: 32717951 DOI: 10.3390/cells9081767] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
29 Yang R, Wei M, Yang F, Sheng Y, Ji L. Diosbulbin B induced G2/M cell cycle arrest in hepatocytes by miRNA-186-3p and miRNA-378a-5p-mediated the decreased expression of CDK1. Toxicology and Applied Pharmacology 2018;357:1-9. [DOI: 10.1016/j.taap.2018.08.016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
30 Özdirik B, Stueven AK, Mohr R, Geisler L, Wree A, Knorr J, Demir M, Vucur M, Loosen SH, Benz F, Reiss M, Wiedenmann B, Tacke F, Jann H, Hellberg T, Roderburg C. Analysis of miR-29 Serum Levels in Patients with Neuroendocrine Tumors-Results from an Exploratory Study. J Clin Med 2020;9:E2881. [PMID: 32899973 DOI: 10.3390/jcm9092881] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
31 Behrouzi A, Ashrafian F, Mazaheri H, Lari A, Nouri M, Riazi Rad F, Hoseini Tavassol Z, Siadat SD. The importance of interaction between MicroRNAs and gut microbiota in several pathways. Microb Pathog 2020;144:104200. [PMID: 32289465 DOI: 10.1016/j.micpath.2020.104200] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
32 Souza T, Trairatphisan P, Piñero J, Furlong LI, Saez-Rodriguez J, Kleinjans J, Jennen D. Embracing the Dark Side: Computational Approaches to Unveil the Functionality of Genes Lacking Biological Annotation in Drug-Induced Liver Injury. Front Genet 2018;9:527. [PMID: 30515189 DOI: 10.3389/fgene.2018.00527] [Reference Citation Analysis]
33 Dhama K, Latheef SK, Dadar M, Samad HA, Munjal A, Khandia R, Karthik K, Tiwari R, Yatoo MI, Bhatt P, Chakraborty S, Singh KP, Iqbal HMN, Chaicumpa W, Joshi SK. Biomarkers in Stress Related Diseases/Disorders: Diagnostic, Prognostic, and Therapeutic Values. Front Mol Biosci 2019;6:91. [PMID: 31750312 DOI: 10.3389/fmolb.2019.00091] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 10.3] [Reference Citation Analysis]
34 Su WH, Wang CJ, Hung YY, Lu CW, Ou CY, Tseng SH, Tsai CC, Kao YT, Chuang PC. MicroRNA-29a Exhibited Pro-Angiogenic and Anti-Fibrotic Features to Intensify Human Umbilical Cord Mesenchymal Stem Cells-Renovated Perfusion Recovery and Preventing against Fibrosis from Skeletal Muscle Ischemic Injury. Int J Mol Sci 2019;20:E5859. [PMID: 31766662 DOI: 10.3390/ijms20235859] [Reference Citation Analysis]
35 Ye L, Yu Y, Zhao Y. Icariin-induced miR-875-5p attenuates epithelial-mesenchymal transition by targeting hedgehog signaling in liver fibrosis. J Gastroenterol Hepatol 2020;35:482-91. [PMID: 31617598 DOI: 10.1111/jgh.14875] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
36 Ezhilarasan D. MicroRNA interplay between hepatic stellate cell quiescence and activation. Eur J Pharmacol 2020;885:173507. [PMID: 32858048 DOI: 10.1016/j.ejphar.2020.173507] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
37 Besheer T, Elalfy H, Abd El-Maksoud M, Abd El-Razek A, Taman S, Zalata K, Elkashef W, Zaghloul H, Elshahawy H, Raafat D, Elemshaty W, Elsayed E, El-Gilany AH, El-Bendary M. Diffusion-weighted magnetic resonance imaging and micro-RNA in the diagnosis of hepatic fibrosis in chronic hepatitis C virus. World J Gastroenterol 2019; 25(11): 1366-1377 [PMID: 30918429 DOI: 10.3748/wjg.v25.i11.1366] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
38 Li F. Expression and correlation of miR-124 and miR-126 in breast cancer. Oncol Lett 2019;17:5115-9. [PMID: 31186724 DOI: 10.3892/ol.2019.10184] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
39 Zhao L, Cao J, Hu K, Wang P, Li G, He X, Tong T, Han L. RNA-binding protein RPS3 contributes to hepatocarcinogenesis by post-transcriptionally up-regulating SIRT1. Nucleic Acids Res 2019;47:2011-28. [PMID: 30517713 DOI: 10.1093/nar/gky1209] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 8.3] [Reference Citation Analysis]
40 Messner CJ, Schmidt S, Özkul D, Gaiser C, Terracciano L, Krähenbühl S, Suter-Dick L. Identification of miR-199a-5p, miR-214-3p and miR-99b-5p as Fibrosis-Specific Extracellular Biomarkers and Promoters of HSC Activation. Int J Mol Sci 2021;22:9799. [PMID: 34575957 DOI: 10.3390/ijms22189799] [Reference Citation Analysis]
41 Kim HG, Cho JH, Kim J, Kim SJ. The Role of Epigenetic Changes in the Progression of Alcoholic Steatohepatitis. Front Physiol 2021;12:691738. [PMID: 34335299 DOI: 10.3389/fphys.2021.691738] [Reference Citation Analysis]
42 Gogulski M, Cieślak A, Grabska J, Ardois M, Pomorska-Mól M, Kołodziejski PA, Libera K, Strompfová V, Szumacher-Strabel M. Effects of silybin supplementation on nutrient digestibility, hematological parameters, liver function indices, and liver-specific mi-RNA concentration in dogs. BMC Vet Res 2021;17:228. [PMID: 34174886 DOI: 10.1186/s12917-021-02929-3] [Reference Citation Analysis]
43 González-Palomo AK, Saldaña-Villanueva K, Cortés-García JD, Fernández-Macias JC, Méndez-Rodríguez KB, Pérez Maldonado IN. Effect of silver nanoparticles (AgNPs) exposure on microRNA expression and global DNA methylation in endothelial cells EA.hy926. Environ Toxicol Pharmacol 2021;81:103543. [PMID: 33166681 DOI: 10.1016/j.etap.2020.103543] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
44 Borji M, Nourbakhsh M, Shafiee SM, Owji AA, Abdolvahabi Z, Hesari Z, Ilbeigi D, Seiri P, Yousefi Z. Down-Regulation of SIRT1 Expression by mir-23b Contributes to Lipid Accumulation in HepG2 Cells. Biochem Genet 2019;57:507-21. [PMID: 30697640 DOI: 10.1007/s10528-019-09905-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
45 Balasubramaniyan N, Devereaux MW, Orlicky DJ, Sokol RJ, Suchy FJ. miR-199a-5p inhibits the Expression of ABCB11 in Obstructive Cholestasis. J Biol Chem 2021;:101400. [PMID: 34774795 DOI: 10.1016/j.jbc.2021.101400] [Reference Citation Analysis]
46 Liang X, Zheng S, Cui J, Yu D, Yang G, Zhou L, Wang B, Cai L, Li W. Alterations of MicroRNA Expression in the Liver, Heart, and Testis of Mice Upon Exposure to Repeated Low-Dose Radiation. Dose Response 2018;16:1559325818799561. [PMID: 30263020 DOI: 10.1177/1559325818799561] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
47 Casciaro M, Di Salvo E, Brizzi T, Rodolico C, Gangemi S. Involvement of miR-126 in autoimmune disorders. Clin Mol Allergy 2018;16:11. [PMID: 29743819 DOI: 10.1186/s12948-018-0089-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
48 Merlin S, Follenzi A. Transcriptional Targeting and MicroRNA Regulation of Lentiviral Vectors. Mol Ther Methods Clin Dev 2019;12:223-32. [PMID: 30775404 DOI: 10.1016/j.omtm.2018.12.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
49 Gholizadeh M, Szelag-Pieniek S, Post M, Kurzawski M, Prieto J, Argemi J, Drozdzik M, Kaderali L. Identifying Differentially Expressed MicroRNAs, Target Genes, and Key Pathways Deregulated in Patients with Liver Diseases. Int J Mol Sci 2020;21:E7368. [PMID: 33036164 DOI: 10.3390/ijms21197368] [Reference Citation Analysis]
50 Chandan K, Gupta M, Sarwat M. Role of Host and Pathogen-Derived MicroRNAs in Immune Regulation During Infectious and Inflammatory Diseases. Front Immunol 2019;10:3081. [PMID: 32038627 DOI: 10.3389/fimmu.2019.03081] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 15.5] [Reference Citation Analysis]
51 Zhang Y, Guo J, Li Y, Jiao K, Zhang Y. let-7a suppresses liver fibrosis via TGFβ/SMAD signaling transduction pathway. Exp Ther Med 2019;17:3935-42. [PMID: 31007736 DOI: 10.3892/etm.2019.7457] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]